Open, agile, and distributed pipelines are changing research. Join us to see how technology will update clinical trials.
Join Drs. Sam Volchenboum and Sam Blackman for a deep dive into the dramatic changes technology is driving in both academic and industry--pharmaceutical and biotechnological--drug development research.
What we know for certain is that drug development pipelines are slow, unwieldy and enormously expensive to advance.
Discovering new therapeutics and biologics is--like Hollywood--a business driven by hits. Single blockbusters are expected to cover the expenses for a researcher’s entire slate of tests. Today these pipelines are increasingly being developed with the assistance of digital technology in order to allow researchers to be be more agile, open, and distributed.